Chart: FDA’s ANDA Approvals

FDA's ANDA Approvals
Applicant	Active Ingredients	Number	Date Approved
Silarx	Fluoxetine oral solution USP, 20 mg/5 mL	77-849	2/9/2007
Murty	Dipyridamole USP, 25 mg, 50 mg and 75 mg tabs.	40-733	2/13/2007
Actavis Elizabeth	Alprazolam, 0.5 mg, 1 mg, 2 mg and 3 mg extended-release tabs.	78-056	2/13/2007
Mylan	Propranolol HCl, 60 mg, 80 mg, 120 mg and 160 mg extended-release caps.	78-022	2/15/2007
Bedford	Methylprednisolone sodium succinate for inj. USP, 125 mg (base), 500 mg (base) and 1 g (base); packaged in single-dose vials	40-641	2/21/2007
Bedford	Methylprednisolone sodium succinate for inj. USP, 40 mg (base); packaged in single-dose vials	40-662	2/21/2007
Bedford	Methylprednisolone sodium succinate for inj. USP, 500 mg (base) and 1 g (base); packaged in multiple-dose vials	40-709	2/21/2007
Actavis MidAtlantic	Ranitidine oral solution USP, 15 mg/mL	76-124	2/21/2007
Teva	Rabeprazole sodium, 20 mg delayed-release tabs.	76-822	2/21/2007
Corepharma	Zonisamide, 25 mg, 50 mg and 100 mg caps.	77-876	2/21/2007
Tentative Approvals
Roxane	Ropinirole HCl, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg and 5 mg tabs.	77-852	2/9/2007
Sicor	Sumatriptan succinate inj., 6 mg (base)/0.5 mL single-dose vial	77-907	2/13/2007
Watson	Albuterol sulfate and ipratropium bromide inhalation solution, 3 mg (0.083%) and 0.5 mg (0.071%)	77-559	2/21/2007
Taro	Ranitidine syrup (ranitidine oral solution, USP), 15 mg/mL	77-476	2/22/2007